Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0A3ES
|
|||
| Former ID |
DIB004815
|
|||
| Drug Name |
OX-51
|
|||
| Synonyms |
Alfentanil hydrochloride; Rapifen; Alfentanil HCl; 69049-06-5; UNII-333JTI7A2M; Alfentanil hydrochloride [USAN]; EINECS 273-846-3; R 39209; 333JTI7A2M; MLS002320667; Propanamide, N-(1-(2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl)-4-(methoxymethyl)-4-piperidinyl)-N-phenyl-, monohydrochloride; N-(1-(2-(4-Ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl)-4-(methoxymethyl)piperidin-4-yl)-N-phenylpropionamide hydrochloride; NCGC00247354-02; SMR001338813; Fentalim; OX-51; Alfentanyl Hydrochloride; AC1L21VB; DSSTox_RID_83122
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Pain [ICD-11: MG30-MG3Z] | Phase 2 | [1] | |
| Company |
Orexo AB
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H33ClN6O3
|
|||
| Canonical SMILES |
CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC.Cl
|
|||
| InChI |
1S/C21H32N6O3.ClH/c1-4-19(28)27(18-9-7-6-8-10-18)21(17-30-3)11-13-24(14-12-21)15-16-26-20(29)25(5-2)22-23-26;/h6-10H,4-5,11-17H2,1-3H3;1H
|
|||
| InChIKey |
AQORHZJDCHLLJN-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 69049-06-5
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| ADReCS Drug ID | BADD_D00068 | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033741) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.